APA (7th ed.) Citation

Zhu, Y., Zhou, J., Zhang, Z., Zhang, J., Fei, J., & Zhu, X. Efficacy and safety of NeoAdjuvant chemotherapy with or without tIslelizumab followed by debulking surgery for oVarian cancEr (NAIVE study) in China: Study protocol of an open-label, phase II, randomised controlled trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Zhu, Ying, Jianwei Zhou, Zhigang Zhang, Jiaojiao Zhang, Jing Fei, and Xiaoqing Zhu. Efficacy and Safety of NeoAdjuvant Chemotherapy with or Without TIslelizumab Followed by Debulking Surgery for OVarian CancEr (NAIVE Study) in China: Study Protocol of an Open-label, Phase II, Randomised Controlled Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Zhu, Ying, et al. Efficacy and Safety of NeoAdjuvant Chemotherapy with or Without TIslelizumab Followed by Debulking Surgery for OVarian CancEr (NAIVE Study) in China: Study Protocol of an Open-label, Phase II, Randomised Controlled Trial. BMJ Publishing Group.